Redmile Group as of Sept. 30, 2024
Portfolio Holdings for Redmile Group
Redmile Group holds 63 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Krystal Biotech (KRYS) | 8.7 | $148M | 810k | 182.03 | |
| Nurix Therapeutics (NRIX) | 5.7 | $96M | 4.3M | 22.47 | |
| Amicus Therapeutics (FOLD) | 5.2 | $88M | 8.2M | 10.68 | |
| Immunome (IMNM) | 4.2 | $72M | 4.9M | 14.62 | |
| Kymera Therapeutics (KYMR) | 3.9 | $66M | 1.4M | 47.33 | |
| Zymeworks Del (ZYME) | 3.8 | $64M | 5.1M | 12.55 | |
| Stoke Therapeutics (STOK) | 3.4 | $58M | 4.7M | 12.29 | |
| Replimune Group (REPL) | 3.1 | $52M | 4.8M | 10.96 | |
| Biohaven (BHVN) | 3.0 | $52M | 1.0M | 49.97 | |
| Regenxbio Inc equity us cm (RGNX) | 3.0 | $51M | 4.9M | 10.49 | |
| Igm Biosciences (IGMS) | 3.0 | $51M | 3.1M | 16.54 | |
| Adc Therapeutics Sa SHS (ADCT) | 2.9 | $49M | 16M | 3.15 | |
| Cogent Biosciences (COGT) | 2.9 | $48M | 4.5M | 10.80 | |
| Fate Therapeutics (FATE) | 2.7 | $46M | 13M | 3.50 | |
| Livanova SHS (LIVN) | 2.7 | $46M | 875k | 52.54 | |
| Scholar Rock Hldg Corp (SRRK) | 2.5 | $42M | 5.2M | 8.01 | |
| Neurogene (NGNE) | 2.4 | $41M | 964k | 41.96 | |
| Akero Therapeutics (AKRO) | 2.3 | $40M | 1.4M | 28.69 | |
| Beam Therapeutics (BEAM) | 2.3 | $40M | 1.6M | 24.50 | |
| Augmedix (AUGX) | 2.3 | $39M | 16M | 2.35 | |
| Annexon (ANNX) | 2.2 | $38M | 6.4M | 5.92 | |
| Catalent | 2.1 | $36M | 596k | 60.57 | |
| Pliant Therapeutics (PLRX) | 2.1 | $36M | 3.2M | 11.21 | |
| Silence Therapeutics Ads (SLN) | 2.0 | $35M | 1.9M | 18.18 | |
| Keros Therapeutics (KROS) | 1.9 | $32M | 553k | 58.07 | |
| Absci Corp (ABSI) | 1.9 | $32M | 8.3M | 3.82 | |
| Boston Scientific Corporation (BSX) | 1.6 | $28M | 331k | 83.80 | |
| Celldex Therapeutics Com New (CLDX) | 1.3 | $22M | 657k | 33.99 | |
| Ideaya Biosciences (IDYA) | 1.3 | $22M | 681k | 31.68 | |
| Shattuck Labs (STTK) | 1.2 | $20M | 5.6M | 3.49 | |
| Biontech Se Sponsored Ads (BNTX) | 1.1 | $18M | 155k | 118.77 | |
| Immunovant (IMVT) | 1.1 | $18M | 642k | 28.51 | |
| 4d Molecular Therapeutics In (FDMT) | 0.8 | $14M | 1.3M | 10.81 | |
| Intuitive Surgical Com New (ISRG) | 0.8 | $13M | 27k | 491.27 | |
| Stryker Corporation (SYK) | 0.7 | $12M | 33k | 361.26 | |
| 89bio (ETNB) | 0.7 | $12M | 1.6M | 7.40 | |
| Ardelyx (ARDX) | 0.7 | $11M | 1.7M | 6.89 | |
| Establishment Labs Holdings Ord (ESTA) | 0.7 | $11M | 262k | 43.27 | |
| Oruka Therapeutics (ORKA) | 0.6 | $10M | 412k | 24.51 | |
| Prime Medicine (PRME) | 0.5 | $8.0M | 2.1M | 3.87 | |
| Alx Oncology Hldgs (ALXO) | 0.4 | $7.0M | 3.8M | 1.82 | |
| Nuvation Bio Com Cl A (NUVB) | 0.4 | $6.9M | 3.0M | 2.29 | |
| Verve Therapeutics (VERV) | 0.4 | $6.7M | 1.4M | 4.84 | |
| Repare Therapeutics Ord (RPTX) | 0.4 | $6.7M | 1.9M | 3.44 | |
| Ac Immune Sa SHS (ACIU) | 0.4 | $6.4M | 1.7M | 3.78 | |
| Cytokinetics Com New (CYTK) | 0.3 | $5.1M | 97k | 52.80 | |
| Ventyx Biosciences (VTYX) | 0.3 | $4.6M | 2.1M | 2.18 | |
| Stereotaxis Com New (STXS) | 0.3 | $4.3M | 2.1M | 2.04 | |
| Atara Biotherapeutics Com New (ATRA) | 0.2 | $3.7M | 452k | 8.13 | |
| Boundless Bio (BOLD) | 0.2 | $3.6M | 1.0M | 3.47 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.2 | $3.4M | 2.1M | 1.66 | |
| Astria Therapeutics (ATXS) | 0.2 | $3.4M | 311k | 11.01 | |
| Adagio Therapeutics (IVVD) | 0.2 | $3.1M | 3.1M | 1.02 | |
| Xeris Pharmaceuticals (XERS) | 0.2 | $3.0M | 1.0M | 2.85 | |
| Gritstone Oncology Ord (GRTSQ) | 0.2 | $2.9M | 4.9M | 0.58 | |
| Penumbra (PEN) | 0.2 | $2.7M | 14k | 194.31 | |
| Cabaletta Bio (CABA) | 0.1 | $2.1M | 443k | 4.72 | |
| Allakos | 0.1 | $2.0M | 3.1M | 0.65 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $1.6M | 1.6M | 1.02 | |
| Allovir (ALVR) | 0.1 | $1.5M | 1.9M | 0.81 | |
| Rapt Therapeutics | 0.1 | $1.0M | 505k | 2.01 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.0 | $680k | 716k | 0.95 | |
| Hookipa Pharma Com New (HOOK) | 0.0 | $457k | 106k | 4.30 |
